Clinical factors affecting acquired resistance to gefitinib in previously treated Japanese patients with advanced nonsmall cell lung cancer.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);脑肿瘤(Brain Neoplasms);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);人类(Humans);日本(Japan);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);喹唑啉类(Quinazolines);回顾性研究(Retrospective Studies);危险因素(Risk Factors)
DOI
10.1002/cncr.22207
PMID
16967452
发布时间
2018-12-01
- 浏览37

Cancer
1866-72页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文